Clin2
NCT06736769Possibly a fitEnrolling by invitation

Ketamine and learning in eating disorders

Anorexia NervosaAtypical Anorexia Nervosa

Treatments studied

Part of Mental health clinical trials.

This study tests whether a single dose of ketamine can help people with anorexia nervosa learn new ways of thinking about food and body image during recovery. You may be eligible if you are a teenager or young adult currently hospitalized for malnutrition.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
20 people
Ages
16 years to 26 years
Study type
Interventional

Who can take part

  • You are between 16 and 26 years old
  • You have anorexia or atypical anorexia and are in the hospital for malnutrition
  • Your psychiatric medications have been stable for at least one month
  • You agree to use effective birth control for two weeks after receiving ketamine (if applicable)
  • You have a regular doctor or therapist managing your care outside the hospital

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06000774Recruiting
Therapeutic Ketogenic Diet for Anorexia Nervosa

This study tests whether a therapeutic ketogenic diet (a very low-carb, high-fat eating plan) can help people with anorexia nervosa, including those who have recently recovered their weight and those who are still underweight. The diet may help improve brain function and reduce eating disorder symptoms.

San Diego, California
NCT07801703Not yet recruiting· Phase 2/Phase 3
Ketamine and therapy for treatment-resistant depression

This study combines behavioral activation therapy (a type of counseling that helps you re-engage in positive activities) with ketamine infusions to treat depression that hasn't improved with standard antidepressants. The goal is to see if adding this therapy makes ketamine work better and last longer.

Ottawa, Ontario
NCT06668571Recruiting· Phase 2
Ketamine for treatment-resistant depression

This study tests if intravenous ketamine can help people with treatment-resistant depression who haven't found relief from at least two other treatments. If you qualify, you'll receive ketamine infusions to see if it improves your mood.

Rochester, Minnesota
NCT02122562Recruiting· Phase 2
Ketamine treatment for depression that hasn’t responded to care

This Phase 2 study tests ketamine for people with major depression that hasn’t improved after at least one antidepressant. It aims to see whether ketamine can reduce depression symptoms during a current depressive episode.

Iowa City, Iowa
NCT06788249Recruiting· Early Phase 1
Ketamine for treatment-resistant depression brain study

This trial tests whether a single dose of ketamine can quickly improve depression by studying brain chemical changes using MRI. It's for people with treatment-resistant depression who haven't used ketamine before.

Philadelphia, Pennsylvania
NCT07139106Not yet recruiting· Phase 4
Ketamine for suicidal thoughts in depression

This study tests whether ketamine can help reduce suicidal thoughts in people with depression. It also looks at how ketamine affects a brain receptor that may be linked to mood and stress, to learn why it might help.

New York, New York

Hear when a new Anorexia Nervosa trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.